Lisa Marks
Overview
Explore the profile of Lisa Marks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Ruiz A, Misra L, Lamb L, Files J, Haerter S, Marks L, et al.
Womens Health Rep (New Rochelle)
. 2025 Jan;
6(1):29-36.
PMID: 39882140
Introduction: Trust and rapport between patients and physicians form the cornerstone of effective medical practice. A key factor influencing this trust is the patient's perception of the physician's appearance. Women...
2.
Shihab S, Islam N, Kanani D, Marks L, Vegunta S
Maturitas
. 2024 Aug;
189:108092.
PMID: 39180900
Alcohol use disorder stands as a prevalent global issue, contributing to 140,000 annual deaths in the United States and causing numerous adverse health and socioeconomic outcomes. Despite being a natural...
3.
Breen I, Stepanek J, Marks L, Yale K, Mesinkovska N, Swanson D
Aerosp Med Hum Perform
. 2024 Aug;
95(9):695-702.
PMID: 39169485
Decompression sickness (DCS) is a medical condition caused by outgassing of dissolved nitrogen following rapid ascent by divers and aviators. Cutaneous DCS, historically termed cutis marmorata (CM), presents as a...
4.
Guidelines for management of actual or suspected inadvertent intra-arterial injection of sclerosants
Parsi K, De Maeseneer M, van Rij A, Rogan C, Bonython W, Devereux J, et al.
Phlebology
. 2024 Jul;
39(10):683-719.
PMID: 39046331
Background: Inadvertent intra-arterial injection of sclerosants is an uncommon adverse event of both ultrasound-guided and direct vision sclerotherapy. This complication can result in significant tissue or limb loss and significant...
5.
Dunn R, Ham K, Marks L, Agrwal N
Cleve Clin J Med
. 2024 Jul;
91(7):405-407.
PMID: 38950983
No abstract available.
6.
Gill V, Sullivan G, Stearns H, Tummala S, Haglin J, Economopoulos K, et al.
Sports Med
. 2024 Feb;
54(6):1-18.
PMID: 38407749
Background And Objective: Previous systematic reviews on mental health in athletes have found athletes to be at a potentially increased risk for mental health diagnoses compared to the public. Multiple...
7.
Gill V, Tummala S, Han W, Boddu S, Verhey J, Marks L, et al.
Arthroscopy
. 2024 Jan;
40(8):2309-2321.e2.
PMID: 38220029
Purpose: To systematically review the existing literature on the functional performance of athletes at the time of return-to-sport (RTS) clearance after anterior cruciate ligament reconstruction (ACLR). Methods: A systematic literature...
8.
Gill V, Tummala S, Sullivan G, Han W, Haglin J, Marks L, et al.
Arthroscopy
. 2024 Jan;
40(7):2135-2151.e2.
PMID: 38216071
Purpose: To systematically review the relationship between functional testing at the time of return to sport (RTS) and short-term outcomes, such as second anterior cruciate ligament (ACL) tear and return...
9.
Brar T, Marks L, Lal D
Front Allergy
. 2023 Jun;
4:1165271.
PMID: 37284022
Background: Epigenetics facilitates insights on the impact of host environment on the genesis of chronic rhinosinusitis (CRS) through modulations of host gene expression and activity. Epigenetic mechanisms such as DNA...
10.
Ramkumar S, Marks L, Lal D, Marino M
Int Forum Allergy Rhinol
. 2023 May;
13(11):2096-2100.
PMID: 37184241
There is no consensus on the extent of appropriate surgery for chronic rhinosinusitis (CRS), particularly CRS without polyps (CRSsNP). There is wide heterogeneity in the definition of "limited" and "extensive"...